company background image
0KW4 logo

ResMed LSE:0KW4 Stock Report

Last Price

US$177.41

Market Cap

US$26.1b

7D

-6.8%

1Y

-20.8%

Updated

18 Apr, 2024

Data

Company Financials +

0KW4 Stock Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.

0KW4 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

ResMed Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ResMed
Historical stock prices
Current Share PriceUS$177.41
52 Week HighUS$240.00
52 Week LowUS$132.67
Beta0.67
1 Month Change-7.39%
3 Month Change3.15%
1 Year Change-20.80%
3 Year Change-15.32%
5 Year Change75.93%
Change since IPO72.58%

Recent News & Updates

Recent updates

Shareholder Returns

0KW4GB Medical EquipmentGB Market
7D-6.8%-1.4%-1.4%
1Y-20.8%-7.8%-2.4%

Return vs Industry: 0KW4 underperformed the UK Medical Equipment industry which returned -7.8% over the past year.

Return vs Market: 0KW4 underperformed the UK Market which returned -2.4% over the past year.

Price Volatility

Is 0KW4's price volatile compared to industry and market?
0KW4 volatility
0KW4 Average Weekly Movement5.1%
Medical Equipment Industry Average Movement7.9%
Market Average Movement4.9%
10% most volatile stocks in GB Market11.5%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0KW4 has not had significant price volatility in the past 3 months.

Volatility Over Time: 0KW4's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198910,140Mick Farrellwww.resmed.com

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.

ResMed Inc. Fundamentals Summary

How do ResMed's earnings and revenue compare to its market cap?
0KW4 fundamental statistics
Market capUS$26.09b
Earnings (TTM)US$890.39m
Revenue (TTM)US$4.50b

29.3x

P/E Ratio

5.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0KW4 income statement (TTM)
RevenueUS$4.50b
Cost of RevenueUS$1.99b
Gross ProfitUS$2.52b
Other ExpensesUS$1.63b
EarningsUS$890.39m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)6.06
Gross Margin55.86%
Net Profit Margin19.77%
Debt/Equity Ratio27.4%

How did 0KW4 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

30%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.